| Ytd | -79.32% | |
| 1y | -82.55% |
| Open | 6.18 | Prev Close | 6.07 | Low | 6.18 | High | 6.18 | Mkt Cap | 52.15M |
| Vol | 5.59K | Avg Vol | 199.02K | EPS | 0.33 | P/E | 18.38 | Forward P/E | N/A |
| Beta | 1.42 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 12.71 | 200-d Avg | 23.07 | 1yr Est | 0.00 |
SNWV News
Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday
Gainers Exicure (NASDAQ:XCUR) stock rose 38.4% to $2.38 during Tuesday's after-market session.
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 56.1% to $4.62 during Monday's after-
SANUWAVE Health (NASDAQ:SNWV) raises Q2 sales outlook from $8.500 million-$9.500 million to $9.600 m
EDEN PRAIRIE, Minn., July 13, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the “Company” or “Sanu
Gainers Quantum Cyber (NASDAQ:QUCY) stock moved upwards by 63.4% to $2.37 during Friday's pre-m
Sanuwave updates guidance for Q2 2026 to $8.5 - $9.5 million Company on pace for record unit sales o
Sanuwave Health NASDAQ: SNWV reported record first-quarter revenue and rising consumables utilizatio
SANUWAVE Health, Inc. (SNWV) Q1 2026 Earnings Call Transcript
Sanuwave Health Inc. (SNWV) came out with a quarterly loss of $0.17 per share versus the Zacks Conse
Q1 2026 revenues were $9.6 million , up 3.1% from $9.3 million in Q1 2025. This represents the high
EDEN PRAIRIE, Minn. , May 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanu
Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely
Ayr Wellness (OTCMKTS:AYRWF - Get Free Report) and Sanuwave Health (NASDAQ: SNWV - Get Free Report)
On April 10, 2026, SANUWAVE Health Inc (SNWV) shares fell 7.2% to a current price of $16.84. The sto
Sanuwave Health (NASDAQ: SNWV - Get Free Report) and INLIF (NASDAQ: INLF - Get Free Report) are both
SANUWAVE Health, Inc. (SNWV) Q4 2025 Earnings Call Transcript
Q4 2025 revenues were $13.4 million , up 29.7% from Q4 2024. This was an all-time quarterly record
EDEN PRAIRIE, Minn., March 20, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "San
Profitability This table compares Arch Therapeutics and SANUWAVE Health's net margins, return on equ
Sanuwave Health Reports Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year
InfuSystem (NYSE: INFU - Get Free Report) and SANUWAVE Health (OTCMKTS:SNWV - Get Free Report) are b
Valuation and Earnings This table compares SANUWAVE Health and Carmell"s revenue, earnings per share
AWM Investment Company Inc. reduced its position in Sanuwave Health Inc. (NASDAQ: SNWV) by 4.6% in t
